Deep Blue Medical Advances
Durham
About Deep Blue Medical Advances
Deep Blue is developing a novel hernia mesh to address the unacceptably high rate of hernia occurrence and recurrence. Millions of hernia surgeries are done globally with billions of dollars in clinical cost. Their surgeon-invented mesh with integral suture-like extensions is designed to eliminate a key point of failure for conventional mesh fixation - the mesh, suture, tissue interface - and to provide superior anchor strength. In addition, Their Anchor Clip fixation device design enables faster, stronger, easier mesh implantation. Deep Blue products enhance hernia surgery with a potentially significant impact on the $1.1B global hernia device market. Due to its simple yet revolutionary design, the T-Line Mesh has the potential to reduce hernia occurrence and recurrence by preventing or reducing mesh fixation failure.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $11.3M
- Funding stage: Early Stage Venture
- Last round: Series A (Jun 2022)
- Website: deepbluemedical.com
Industries & Categories
Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/deep-blue-medical-advances-179935 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.